These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9613453)

  • 1. Antiangiogenesis and apoptosis as mediators of concomitant tumor resistance induced by Calu-6, a human lung carcinoma cell line, in nude mice.
    Bonfil RD; Bustuoabad OD; Binda MM
    Oncol Res; 1998; 10(1):15-21. PubMed ID: 9613453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
    Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N
    Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice.
    Goto H; Yano S; Zhang H; Matsumori Y; Ogawa H; Blakey DC; Sone S
    Cancer Res; 2002 Jul; 62(13):3711-5. PubMed ID: 12097279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo.
    Mukhopadhyay T; Sasaki J; Ramesh R; Roth JA
    Clin Cancer Res; 2002 Sep; 8(9):2963-9. PubMed ID: 12231542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.
    Onn A; Isobe T; Itasaka S; Wu W; O'Reilly MS; Ki Hong W; Fidler IJ; Herbst RS
    Clin Cancer Res; 2003 Nov; 9(15):5532-9. PubMed ID: 14654533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
    Keyes KA; Mann L; Cox K; Treadway P; Iversen P; Chen YF; Teicher BA
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):321-7. PubMed ID: 12721760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of suramin in combination with cisplatin on growth and metastasis of lung adenocarcinoma xenografts in mice].
    Zhang P; He JB; Ou LW; Wang XH
    Ai Zheng; 2006 Apr; 25(4):409-13. PubMed ID: 16613671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide.
    Cao QZ; Lin ZB
    Acta Pharmacol Sin; 2004 Jun; 25(6):833-8. PubMed ID: 15169641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and enhanced angiogenesis do not promote metastatic conversion of a newly established azoxymethane-induced colon cancer cell line.
    Belinsky GS; Claffey KP; Nambiar PR; Guda K; Rosenberg DW
    Mol Carcinog; 2005 Jun; 43(2):65-74. PubMed ID: 15768385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
    Chen XY; Zhang W; Zhang W; Wu S; Bi F; Su YJ; Tan XY; Liu JN; Zhang J
    Clin Cancer Res; 2006 Oct; 12(19):5834-40. PubMed ID: 17020991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.
    Schiller JH; Bittner G
    Clin Cancer Res; 1999 Dec; 5(12):4287-94. PubMed ID: 10632372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.